MKS Instruments Reports Second Quarter 2024 Financial Results
MKS Instruments (NASDAQ: MKSI) reported strong Q2 2024 financial results, with revenue of $887 million at the high end of guidance. The company posted GAAP net income of $23 million and net income per share of $0.33. Adjusted EBITDA reached $228 million, while Non-GAAP net earnings per diluted share were $1.53, exceeding the high-end of guidance.
CEO John T.C. Lee highlighted the company's strong execution in Semiconductor and Electronics & Packaging markets, emphasizing MKS's role as a critical enabler in chipmaking and advanced electronics. For Q3 2024, MKS expects revenue of $870 million (±$40 million), Adjusted EBITDA of $206 million (±$23 million), and Non-GAAP net earnings per diluted share of $1.43 (±$0.28).
MKS Instruments (NASDAQ: MKSI) ha riportato risultati finanziari solidi per il secondo trimestre del 2024, con un fatturato di $887 milioni, al limite superiore delle indicazioni fornite. L'azienda ha registrato un utile netto GAAP di $23 milioni e un utile netto per azione di $0,33. L'EBITDA adeguato ha raggiunto $228 milioni, mentre l'utile netto non GAAP per azione diluita è stato di $1,53, superando il limite superiore delle previsioni.
Il CEO John T.C. Lee ha messo in evidenza l'ottima esecuzione dell'azienda nei mercati dei semiconduttori e dell'elettronica e imballaggio, enfatizzando il ruolo di MKS come abilitante critico nella produzione di chip e nell'elettronica avanzata. Per il terzo trimestre del 2024, MKS prevede un fatturato di $870 milioni (±$40 milioni), un EBITDA adeguato di $206 milioni (±$23 milioni) e un utile netto non GAAP per azione diluita di $1,43 (±$0,28).
MKS Instruments (NASDAQ: MKSI) reportó resultados financieros sólidos para el segundo trimestre de 2024, con ingresos de $887 millones, en el extremo superior de las proyecciones. La compañía publicó un ingreso neto GAAP de $23 millones y un ingreso neto por acción de $0,33. El EBITDA ajustado alcanzó $228 millones, mientras que las ganancias netas no GAAP por acción diluida fueron de $1,53, superando el límite superior de las proyecciones.
El CEO John T.C. Lee destacó la sólida ejecución de la compañía en los mercados de semiconductores y electrónica y embalaje, enfatizando el papel de MKS como un facilitador crítico en la fabricación de chips y en la electrónica avanzada. Para el tercer trimestre de 2024, MKS espera ingresos de $870 millones (±$40 millones), un EBITDA ajustado de $206 millones (±$23 millones) y ganancias netas no GAAP por acción diluida de $1,43 (±$0,28).
MKS Instruments (NASDAQ: MKSI)는 2024년 2분기 강력한 재무 결과를 보고했으며, 수익은 $887백만으로 가이던스의 상단에 위치해 있습니다. 이 회사는 GAAP 기준 순이익 $23백만과 주당 순이익 $0.33을 기록했습니다. 조정된 EBITDA는 $228백만에 도달하였으며, 희석 주당 비-GAAP 순이익은 $1.53으로 가이던스의 상한을 초과했습니다.
CEO John T.C. Lee는 반도체 및 전자 및 포장 시장에서 회사의 강력한 실행력을 강조했고, MKS가 칩 제조와 고급 전자제품에서 핵심적인 역할을 한다고 강조했습니다. 2024년 3분기 동안, MKS는 수익이 $870백만 (±$40백만), 조정된 EBITDA가 $206백만 (±$23백만), 희석 주당 비-GAAP 순이익이 $1.43 (±$0.28)될 것으로 예상합니다.
MKS Instruments (NASDAQ: MKSI) a annoncé de solides résultats financiers pour le deuxième trimestre 2024, avec un chiffre d'affaires de $887 millions, à l'extrémité supérieure des prévisions. La société a enregistré un résultat net GAAP de 23 millions de dollars et un résultat net par action de 0,33 $. L'EBITDA ajusté a atteint $228 millions, tandis que le résultat net non GAAP par action diluée était de $1,53, dépassant le haut de la fourchette de prévisions.
Le PDG John T.C. Lee a souligné la solide exécution de l'entreprise sur les marchés des semiconducteurs et de l'électronique et de l'emballage, en soulignant le rôle de MKS en tant que facilitateur clé dans la fabrication de puces et l'électronique avancée. Pour le troisième trimestre 2024, MKS prévoit un chiffre d'affaires de $870 millions (±$40 millions), un EBITDA ajusté de $206 millions (±$23 millions) et un bénéfice net non GAAP par action diluée de $1,43 (±$0,28).
MKS Instruments (NASDAQ: MKSI) hat starke finanzielle Ergebnisse für das zweite Quartal 2024 gemeldet, mit Einnahmen von $887 Millionen, am oberen Ende der Prognose. Das Unternehmen verzeichnete ein GAAP-Nettoeinkommen von $23 Millionen und ein Nettoeinkommen pro Aktie von $0,33. Das bereinigte EBITDA erreichte $228 Millionen, während das bereinigte Nettoergebnis pro verwässerter Aktie $1,53 betrug und die obere Grenze der Prognosen übertraf.
CEO John T.C. Lee hob die starke Umsetzung des Unternehmens in den Bereichen Halbleiter sowie Elektronik und Verpackung hervor und betonte die Rolle von MKS als entscheidenden Enabler in der Chipproduktion und der fortschrittlichen Elektronik. Für das dritte Quartal 2024 erwartet MKS Einnahmen von $870 Millionen (±$40 Millionen), ein bereinigtes EBITDA von $206 Millionen (±$23 Millionen) und ein bereinigtes Nettoergebnis pro verwässerter Aktie von $1,43 (±$0,28).
- Q2 2024 revenue of $887 million, at the high end of guidance
- Adjusted EBITDA of $228 million, exceeding the high-end of guidance
- Non-GAAP net earnings per diluted share of $1.53, surpassing guidance
- Robust gross margins maintained through prudent cost control
- Proactive measures taken to improve debt profile, including convertible notes offering and term loan prepayment
- Muted semiconductor and advanced electronics environment noted
- Slight decrease in expected Q3 2024 revenue compared to Q2 2024
Insights
MKS Instruments' Q2 2024 results demonstrate resilience in a challenging market. Revenue of
The company's ability to maintain robust gross margins amid a muted semiconductor environment showcases effective cost management. However, the
MKS's proactive debt management, including the convertible notes offering and
MKS Instruments' performance underscores its critical role in the semiconductor value chain. Despite the current industry slowdown, MKS's broad product portfolio across chipmaking, package substrates and PCBs has allowed it to outperform expectations.
The company's ability to generate healthy profits in a muted environment speaks to its competitive positioning and operational efficiency. This resilience is important as the semiconductor industry navigates cyclical challenges.
Looking ahead, MKS is well-positioned to capitalize on the eventual upturn in semiconductor demand. Its focus on enabling technologies for advanced packaging and substrates aligns with key industry trends towards more complex chip designs and heterogeneous integration.
- Quarterly revenue of
$887 million , at the high end of guidance - Quarterly GAAP net income of
$23 million and net income per share of$0.33 - Quarterly Adjusted EBITDA of
$228 million and Non-GAAP net earnings per diluted share of$1.53 , exceeding the high-end of guidance
ANDOVER, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today reported second quarter 2024 financial results.
“Our continued execution, especially in our Semiconductor and Electronics & Packaging markets, drove strong financial results in the second quarter. Revenues of
Mr. Lee added, “The team continues to deliver robust gross margins as we closely manage the cost structure through the current cycle. In addition, we have taken proactive measures to improve our debt profile, including our convertible notes offering in May as well as another repricing and voluntary term loan prepayment of
Third Quarter 2024 Outlook
For the third quarter of 2024, the Company expects revenue of
Conference Call Details
A conference call with management will be held on Thursday, August 8, 2024 at 8:30 a.m. (Eastern Time). To participate in the call by phone, participants should visit the Investor Relations section of MKS’ website at investor.mks.com and click on Events & Presentations, where you will be able to register online and receive dial-in details. We encourage participants to register and dial in to the conference call at least 15 minutes before the start of the call to ensure a timely connection. A live and archived webcast and related presentation materials will be available on the Investor Relations section of the MKS website.
About MKS Instruments
MKS Instruments enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world's leading technology and industrial companies. Our solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing by enabling increased power, speed, feature enhancement, and optimized connectivity. Our solutions are also critical to addressing ever-increasing performance requirements across a wide array of specialty industrial applications. Additional information can be found at www.mks.com.
Use of Non-GAAP Financial Results
This press release includes financial measures that are not in accordance with U.S. generally accepted accounting principles (“Non-GAAP financial measures”). These Non-GAAP financial measures should be viewed in addition to, and not as a substitute for, MKS’ reported results under U.S. generally accepted accounting principles (“GAAP”), and may be different from Non-GAAP financial measures used by other companies. In addition, these Non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results.
MKS is not providing a quantitative reconciliation of forward-looking Non-GAAP net earnings per diluted share and Adjusted EBITDA to their most directly comparable GAAP financial measures because we are unable to estimate with reasonable certainty the ultimate timing or amount of certain significant items without unreasonable efforts. These items include, but are not limited to, acquisition and integration costs, amortization of intangible assets, restructuring expense, goodwill and intangible asset impairments, excess and obsolescence inventory charges, amortization of debt issuance costs, debt refinancing fee, loss on extinguishment of debt, and the income tax effect of these items. These items are uncertain, depend on various factors, including, but not limited to, the integration of our acquisition of Atotech Limited (“Atotech”), which we acquired in August 2022 (the “Atotech Acquisition”), and the interest rate and refinancing environment, and could have a material impact on GAAP reported results for the relevant period.
For further information regarding these Non-GAAP financial measures, including a change in the fourth quarter of 2023 to the definition of Adjusted EBITDA, please refer to the tables presenting reconciliations of our Non-GAAP results to our GAAP results and the “Notes on Our Non-GAAP Financial Information” at the end of this press release.
Selected GAAP and Non-GAAP Financial Measures (In millions, except per share data) | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
Q2 2024 | Q1 2024 | Q2 2023 | Q2 2024 | Q2 2023 | |||||||||||||||
Net Revenues | |||||||||||||||||||
Semiconductor | $ | 369 | $ | 351 | $ | 441 | $ | 720 | $ | 750 | |||||||||
Electronics and Packaging | 229 | 208 | 225 | 437 | 447 | ||||||||||||||
Specialty Industrial | 289 | 309 | 337 | 598 | 600 | ||||||||||||||
Total net revenues | $ | 887 | $ | 868 | $ | 1,003 | $ | 1,755 | $ | 1,797 | |||||||||
GAAP Financial Measures | |||||||||||||||||||
Gross margin | 47.3 | % | 47.8 | % | 46.9 | % | 47.5 | % | 44.8 | % | |||||||||
Operating margin | 14.4 | % | 12.2 | % | (169.1 | %) | 13.3 | % | (94.3 | %) | |||||||||
Net income (loss) | $ | 23 | $ | 15 | $ | (1,769 | ) | $ | 37 | $ | (1,812 | ) | |||||||
Diluted income (loss) per share | $ | 0.33 | $ | 0.22 | $ | (26.47 | ) | $ | 0.55 | $ | (27.14 | ) | |||||||
Non-GAAP Financial Measures | |||||||||||||||||||
Gross margin | 47.3 | % | 47.8 | % | 46.9 | % | 47.5 | % | 44.8 | % | |||||||||
Operating margin | 21.7 | % | 20.2 | % | 22.6 | % | 21.0 | % | 17.9 | % | |||||||||
Net earnings | $ | 103 | $ | 79 | $ | 88 | $ | 183 | $ | 120 | |||||||||
Diluted earnings per share | $ | 1.53 | $ | 1.18 | $ | 1.32 | $ | 2.71 | $ | 1.80 | |||||||||
Additional Financial Information
At June 30, 2024, the Company had
In July 2024, the Company completed the repricing of its USD term loan B and its EUR term loan B and made a voluntary prepayment of
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding the future financial performance, business prospects and growth of MKS Instruments, Inc. (“MKS,” the “Company,” “our,” or “we”). These statements are only predictions based on current assumptions and expectations. Any statements that are not statements of historical fact (including statements containing the words “will,” “projects,” “intends,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” “forecasts,” “continues” and similar expressions) should be considered to be forward-looking statements. Actual events or results may differ materially from those in the forward-looking statements set forth herein. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements that we make are the level and terms of our substantial indebtedness; our entry into the chemicals technology business through the Atotech Acquisition, which may expose us to significant additional liabilities; the risk that we are unable to integrate the Atotech Acquisition successfully or realize the anticipated synergies, cost savings and other benefits of the Atotech Acquisition; legal, reputational, financial and contractual risks resulting from the ransomware incident we identified in February 2023, and other risks related to cybersecurity, data privacy and intellectual property; competition from larger, more advanced or more established companies in our markets; the ability to successfully grow our business, including through growth of the Atotech business and growth of the Electro Scientific Industries, Inc. business, which we acquired in February 2019, and financial risks associated with those and potential future acquisitions, including goodwill and intangible asset impairments; manufacturing and sourcing risks, including those associated with limited and sole source suppliers and the impact and duration of supply chain disruptions, component shortages, and price increases; changes in global demand; the impact of a pandemic or other widespread health crisis; risks associated with doing business internationally, including geopolitical conflicts, such as the conflict in the Middle East, trade compliance, regulatory restrictions on our products, components or markets, particularly the semiconductor market, and unfavorable currency exchange and tax rate fluctuations, which risks become more significant as we grow our business internationally and in China specifically; conditions affecting the markets in which we operate, including fluctuations in capital spending in the semiconductor, electronics manufacturing and automotive industries, and fluctuations in sales to our major customers; disruptions or delays from third-party service providers upon which our operations may rely; the ability to anticipate and meet customer demand; the challenges, risks and costs involved with integrating or transitioning global operations of the companies we have acquired; risks associated with the attraction and retention of key personnel; potential fluctuations in quarterly results; dependence on new product development; rapid technological and market change; acquisition strategy; volatility of stock price; risks associated with chemical manufacturing and environmental regulation compliance; risks related to defective products; financial and legal risk management; and the other important factors described under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023 and any subsequent Quarterly Reports on Form 10-Q, each as filed with the U.S. Securities and Exchange Commission. MKS is under no obligation to, and expressly disclaims any obligation to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise, even if subsequent events cause our views to change, after the date of this press release. Amounts reported in this press release are preliminary and subject to finalization prior to the filing of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024.
Company Contact:
Paretosh Misra
Vice President, Investor Relations
Telephone: (978) 284-4705
Email: paretosh.misra@mksinst.com
MKS Instruments, Inc. | |||||||||||||||||||
Unaudited Consolidated Statements of Operations | |||||||||||||||||||
(In millions, except per share data) | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
June 30, | March 31, | June 30, | June 30, | June 30, | |||||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | |||||||||||||||
Net revenues: | |||||||||||||||||||
Products | $ | 770 | $ | 754 | $ | 885 | $ | 1,524 | $ | 1,597 | |||||||||
Services | 117 | 114 | 118 | 231 | 200 | ||||||||||||||
Total net revenues | 887 | 868 | 1,003 | 1,755 | 1,797 | ||||||||||||||
Cost of revenues: | |||||||||||||||||||
Products | 412 | 398 | 470 | 810 | 878 | ||||||||||||||
Services | 56 | 55 | 63 | 111 | 113 | ||||||||||||||
Total cost of revenues (exclusive of amortization shown separately below) | 468 | 453 | 533 | 921 | 991 | ||||||||||||||
Gross profit | 419 | 415 | 470 | 834 | 806 | ||||||||||||||
Research and development | 66 | 70 | 75 | 136 | 147 | ||||||||||||||
Selling, general and administrative | 161 | 170 | 172 | 331 | 348 | ||||||||||||||
Acquisition and integration costs | 2 | 1 | 5 | 3 | 11 | ||||||||||||||
Restructuring and other | 2 | 3 | 11 | 5 | 12 | ||||||||||||||
Fees and expenses related to amendments to the Term Loan Facility | — | 3 | — | 3 | — | ||||||||||||||
Amortization of intangible assets | 61 | 62 | 76 | 123 | 157 | ||||||||||||||
Goodwill and intangible asset impairments | — | — | 1,827 | — | 1,827 | ||||||||||||||
Income (loss) from operations | 127 | 106 | (1,696 | ) | 233 | (1,696 | ) | ||||||||||||
Interest income | (5 | ) | (6 | ) | (4 | ) | (11 | ) | (7 | ) | |||||||||
Interest expense | 79 | 87 | 88 | 166 | 173 | ||||||||||||||
Loss on extinguishment of debt | 38 | 9 | — | 47 | — | ||||||||||||||
Other (income) expense, net | (7 | ) | (3 | ) | 11 | (10 | ) | 9 | |||||||||||
Income (loss) before income taxes | 22 | 19 | (1,791 | ) | 41 | (1,871 | ) | ||||||||||||
(Benefit) provision for income taxes | (1 | ) | 4 | (22 | ) | 4 | (59 | ) | |||||||||||
Net income (loss) | $ | 23 | $ | 15 | $ | (1,769 | ) | $ | 37 | $ | (1,812 | ) | |||||||
Net income (loss) per share: | |||||||||||||||||||
Basic | $ | 0.34 | $ | 0.22 | $ | (26.47 | ) | $ | 0.56 | $ | (27.14 | ) | |||||||
Diluted | $ | 0.33 | $ | 0.22 | $ | (26.47 | ) | $ | 0.55 | $ | (27.14 | ) | |||||||
Cash dividend per common share | $ | 0.22 | $ | 0.22 | $ | 0.22 | $ | 0.44 | $ | 0.44 | |||||||||
Weighted average shares outstanding: | |||||||||||||||||||
Basic | 67.3 | 67.0 | 66.8 | 67.2 | 66.8 | ||||||||||||||
Diluted | 67.5 | 67.4 | 66.8 | 67.5 | 66.8 |
MKS Instruments, Inc. | |||||||
Unaudited Consolidated Balance Sheets | |||||||
(In millions) | |||||||
June 30, | December 31, | ||||||
2024 | 2023 | ||||||
ASSETS | |||||||
Cash and cash equivalents | $ | 850 | $ | 875 | |||
Short-term investments | 1 | — | |||||
Accounts receivable, net | 597 | 603 | |||||
Inventories | 938 | 991 | |||||
Other current assets | 262 | 227 | |||||
Total current assets | 2,648 | 2,696 | |||||
Property, plant and equipment, net | 759 | 784 | |||||
Right-of-use assets, net | 229 | 225 | |||||
Goodwill | 2,495 | 2,554 | |||||
Intangible assets, net | 2,418 | 2,619 | |||||
Other assets | 314 | 240 | |||||
Total assets | $ | 8,863 | $ | 9,118 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Short-term debt | $ | 50 | $ | 93 | |||
Accounts payable | 291 | 327 | |||||
Other current liabilities | 399 | 428 | |||||
Total current liabilities | 740 | 848 | |||||
Long-term debt, net | 4,832 | 4,696 | |||||
Non-current deferred taxes | 588 | 640 | |||||
Non-current accrued compensation | 144 | 151 | |||||
Non-current lease liabilities | 202 | 205 | |||||
Other liabilities | 124 | 106 | |||||
Total liabilities | 6,630 | 6,646 | |||||
Stockholders' equity | |||||||
Common stock | — | — | |||||
Additional paid-in capital | 2,042 | 2,195 | |||||
Retained earnings | 381 | 373 | |||||
Accumulated other comprehensive (loss) income | (190 | ) | (96 | ) | |||
Total stockholders' equity | 2,233 | 2,472 | |||||
Total liabilities and stockholders' equity | $ | 8,863 | $ | 9,118 |
MKS Instruments, Inc. | |||||||||||||||||||
Unaudited Consolidated Statements of Cash Flows | |||||||||||||||||||
(In millions) | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
June 30, | March 31, | June 30, | June 30, | June 30, | |||||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | |||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||
Net income (loss) | $ | 23 | $ | 15 | $ | (1,769 | ) | $ | 37 | $ | (1,812 | ) | |||||||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||||||||||||||||
Depreciation and amortization | 86 | 88 | 101 | 175 | 208 | ||||||||||||||
Goodwill and intangible asset impairments | — | — | 1,827 | — | 1,827 | ||||||||||||||
Unrealized (gain) loss on derivatives not designated as hedging instruments | (3 | ) | 3 | 6 | — | 20 | |||||||||||||
Amortization of debt issuance costs and original issue discounts | 8 | 8 | 7 | 16 | 15 | ||||||||||||||
Loss on extinguishment of debt | 38 | 9 | — | 47 | — | ||||||||||||||
Stock-based compensation | 11 | 15 | 13 | 26 | 31 | ||||||||||||||
Provision for excess and obsolete inventory | 14 | 11 | 12 | 25 | 30 | ||||||||||||||
Deferred income taxes | (59 | ) | (36 | ) | (109 | ) | (95 | ) | (120 | ) | |||||||||
Other | 2 | 2 | 1 | 4 | 1 | ||||||||||||||
Changes in operating assets and liabilities | 2 | (48 | ) | (148 | ) | (46 | ) | (222 | ) | ||||||||||
Net cash provided by (used in) operating activities | 122 | 67 | (59 | ) | 189 | (22 | ) | ||||||||||||
Cash flows from investing activities: | |||||||||||||||||||
Proceeds from sale of long-lived assets | — | — | — | 1 | 1 | ||||||||||||||
Purchases of property, plant and equipment | (26 | ) | (18 | ) | (18 | ) | (45 | ) | (35 | ) | |||||||||
Net cash used in investing activities | (26 | ) | (18 | ) | (18 | ) | (44 | ) | (34 | ) | |||||||||
Cash flows from financing activities: | |||||||||||||||||||
Proceeds from borrowings | 1,400 | 761 | — | 2,161 | 1 | ||||||||||||||
Payments of borrowings | (1,269 | ) | (806 | ) | (22 | ) | (2,075 | ) | (45 | ) | |||||||||
Purchase of capped calls related to Convertible Notes | (167 | ) | — | — | (167 | ) | — | ||||||||||||
Payments of deferred financing fees | (31 | ) | (2 | ) | — | (33 | ) | — | |||||||||||
Dividend payments | (15 | ) | (15 | ) | (15 | ) | (30 | ) | (29 | ) | |||||||||
Net (payments) proceeds related to employee stock awards | (2 | ) | (9 | ) | 1 | (11 | ) | (5 | ) | ||||||||||
Other financing activities | (3 | ) | (1 | ) | 1 | (4 | ) | — | |||||||||||
Net cash used in financing activities | (87 | ) | (72 | ) | (35 | ) | (159 | ) | (78 | ) | |||||||||
Effect of exchange rate changes on cash and cash equivalents | (4 | ) | (7 | ) | (11 | ) | (11 | ) | (18 | ) | |||||||||
Increase (decrease) in cash and cash equivalents | 5 | (30 | ) | (123 | ) | (25 | ) | (152 | ) | ||||||||||
Cash and cash equivalents at beginning of period | 845 | 875 | 880 | 875 | 909 | ||||||||||||||
Cash and cash equivalents at end of period | $ | 850 | $ | 845 | $ | 757 | $ | 850 | $ | 757 | |||||||||
The following supplemental Non-GAAP earnings information is presented to aid in understanding MKS’ operating results: | |||||||||||||||||||
MKS Instruments, Inc. | |||||||||||||||||||
Schedule Reconciling Selected Non-GAAP Financial Measures | |||||||||||||||||||
(In millions, except per share data) | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
June 30, | March 31, | June 30, | June 30, | June 30, | |||||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | |||||||||||||||
Net income (loss) | $ | 23 | $ | 15 | $ | (1,769 | ) | $ | 37 | $ | (1,812 | ) | |||||||
Acquisition and integration costs (Note 1) | 2 | 1 | 5 | 3 | 11 | ||||||||||||||
Restructuring and other (Note 2) | 2 | 3 | 11 | 5 | 12 | ||||||||||||||
Amortization of intangible assets | 61 | 62 | 76 | 123 | 157 | ||||||||||||||
Goodwill and intangible asset impairments (Note 3) | — | — | 1,827 | — | 1,827 | ||||||||||||||
Amortization of debt issuance costs (Note 4) | 5 | 6 | 5 | 11 | 11 | ||||||||||||||
Fees and expenses related to amendments to the Term Loan Facility (Note 5) | — | 3 | — | 3 | — | ||||||||||||||
Ransomware incident (Note 6) | — | — | 4 | — | 11 | ||||||||||||||
Loss on extinguishment of debt (Note 7) | 38 | 9 | — | 47 | — | ||||||||||||||
Foreign tax rate adjustment (Note 8) | — | — | — | — | (2 | ) | |||||||||||||
Tax effect of Non-GAAP adjustments (Note 9) | (28 | ) | (20 | ) | (71 | ) | (46 | ) | (95 | ) | |||||||||
Non-GAAP net earnings | $ | 103 | $ | 79 | $ | 88 | $ | 183 | $ | 120 | |||||||||
Non-GAAP net earnings per diluted share | $ | 1.53 | $ | 1.18 | $ | 1.32 | $ | 2.71 | $ | 1.80 | |||||||||
Weighted average diluted shares outstanding | 67.5 | 67.4 | 67.0 | 67.5 | 66.9 | ||||||||||||||
Net cash provided by (used in) operating activities | $ | 122 | $ | 67 | $ | (59 | ) | $ | 189 | $ | (22 | ) | |||||||
Purchases of property, plant and equipment | (26 | ) | (18 | ) | (18 | ) | (45 | ) | (35 | ) | |||||||||
Free cash flow | $ | 96 | $ | 49 | $ | (77 | ) | $ | 144 | $ | (57 | ) |
MKS Instruments, Inc. | |||||||||||||||||||
Schedule Reconciling Selected Non-GAAP Financial Measures | |||||||||||||||||||
(In millions) | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
June 30, | March 31, | June 30, | June 30, | June 30, | |||||||||||||||
2024 | 2024 | 2023 | 2024 | 2023 | |||||||||||||||
GAAP and Non-GAAP gross profit | $ | 419 | $ | 415 | $ | 470 | $ | 834 | $ | 806 | |||||||||
GAAP and Non-GAAP gross margin | 47.3 | % | 47.8 | % | 46.9 | % | 47.5 | % | 44.8 | % | |||||||||
Operating expenses | $ | 292 | $ | 309 | $ | 2,166 | $ | 601 | $ | 2,502 | |||||||||
Acquisition and integration costs (Note 1) | 2 | 1 | 5 | 3 | 11 | ||||||||||||||
Restructuring and other (Note 2) | 2 | 3 | 11 | 5 | 12 | ||||||||||||||
Amortization of intangible assets | 61 | 62 | 76 | 123 | 157 | ||||||||||||||
Goodwill and intangible asset impairments (Note 3) | — | — | 1,827 | — | 1,827 | ||||||||||||||
Fees and expenses related to amendments to the Term Loan Facility (Note 5) | — | 3 | — | 3 | — | ||||||||||||||
Ransomware incident (Note 6) | — | — | 4 | — | 11 | ||||||||||||||
Non-GAAP operating expenses | $ | 227 | $ | 240 | $ | 243 | $ | 467 | $ | 484 | |||||||||
Income (loss) from operations | $ | 127 | $ | 106 | $ | (1,696 | ) | $ | 233 | $ | (1,696 | ) | |||||||
Operating margin | 14.4 | % | 12.2 | % | (169.1 | %) | 13.3 | % | (94.3 | %) | |||||||||
Acquisition and integration costs (Note 1) | 2 | 1 | 5 | 3 | 11 | ||||||||||||||
Restructuring and other (Note 2) | 2 | 3 | 11 | 5 | 12 | ||||||||||||||
Amortization of intangible assets | 61 | 62 | 76 | 123 | 157 | ||||||||||||||
Goodwill and intangible asset impairments (Note 3) | — | — | 1,827 | — | 1,827 | ||||||||||||||
Fees and expenses related to amendments to the Term Loan Facility (Note 5) | — | 3 | — | 3 | — | ||||||||||||||
Ransomware incident (Note 6) | — | — | 4 | — | 11 | ||||||||||||||
Non-GAAP income from operations | $ | 192 | $ | 175 | $ | 227 | $ | 367 | $ | 322 | |||||||||
Non-GAAP operating margin | 21.7 | % | 20.2 | % | 22.6 | % | 21.0 | % | 17.9 | % | |||||||||
Interest expense, net | $ | 74 | $ | 81 | $ | 84 | $ | 155 | $ | 166 | |||||||||
Amortization of debt issuance costs (Note 4) | 5 | 6 | 5 | 11 | 11 | ||||||||||||||
Non-GAAP interest expense, net | $ | 69 | $ | 75 | $ | 79 | $ | 144 | $ | 155 | |||||||||
Net income (loss) | $ | 23 | $ | 15 | $ | (1,769 | ) | $ | 37 | $ | (1,812 | ) | |||||||
Interest expense, net | 74 | 81 | 84 | 155 | 166 | ||||||||||||||
Other (income) expense, net (Note 10) | (7 | ) | (3 | ) | 11 | (10 | ) | 9 | |||||||||||
(Benefit) provision for income taxes | (1 | ) | 4 | (22 | ) | 4 | (59 | ) | |||||||||||
Depreciation | 25 | 26 | 25 | 52 | 51 | ||||||||||||||
Amortization of intangible assets | 61 | 62 | 76 | 123 | 157 | ||||||||||||||
Stock-based compensation | 11 | 15 | 13 | 26 | 31 | ||||||||||||||
Acquisition and integration costs (Note 1) | 2 | 1 | 5 | 3 | 11 | ||||||||||||||
Restructuring and other (Note 2) | 2 | 3 | 11 | 5 | 12 | ||||||||||||||
Goodwill and intangible asset impairments (Note 3) | — | — | 1,827 | — | 1,827 | ||||||||||||||
Fees and expenses related to amendments to the Term Loan Facility (Note 5) | — | 3 | — | 3 | — | ||||||||||||||
Ransomware incident (Note 6) | — | — | 4 | — | 11 | ||||||||||||||
Loss on extinguishment of debt (Note 7) | 38 | 9 | — | 47 | — | ||||||||||||||
Adjusted EBITDA (Note 10) | $ | 228 | $ | 217 | $ | 265 | $ | 445 | $ | 404 | |||||||||
Adjusted EBITDA margin | 25.7 | % | 25.0 | % | 26.4 | % | 25.4 | % | 22.5 | % |
MKS Instruments, Inc. | |||||||||||||||||||||||
Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate | |||||||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Three Months Ended June 30, 2024 | Three Months Ended March 31, 2024 | ||||||||||||||||||||||
Income Before Income Taxes | (Benefit) Provision for Income Taxes | Effective Tax Rate | Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate | ||||||||||||||||||
GAAP | $ | 22 | $ | (1 | ) | (3.6 | %) | $ | 19 | $ | 4 | 23.1 | % | ||||||||||
Acquisition and integration costs (Note 1) | 2 | — | 1 | — | |||||||||||||||||||
Restructuring and other (Note 2) | 2 | — | 3 | — | |||||||||||||||||||
Amortization of intangible assets | 61 | — | 62 | — | |||||||||||||||||||
Amortization of debt issuance costs (Note 4) | 5 | — | 6 | — | |||||||||||||||||||
Fees and expenses related to amendments to the Term Loan Facility (Note 5) | — | — | 3 | — | |||||||||||||||||||
Loss on extinguishment of debt (Note 7) | 38 | — | 9 | — | |||||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 9) | — | 28 | — | 20 | |||||||||||||||||||
Non-GAAP | $ | 130 | $ | 27 | 20.5 | % | $ | 103 | $ | 24 | 23.3 | % | |||||||||||
Three Months Ended June 30, 2023 | |||||||||||||||||||||||
(Loss) Income Before Income Taxes | (Benefit) Provision for Income Taxes | Effective Tax Rate | |||||||||||||||||||||
GAAP | $ | (1,791 | ) | $ | (22 | ) | 1.2 | % | |||||||||||||||
Acquisition and integration costs (Note 1) | 5 | — | |||||||||||||||||||||
Restructuring and other (Note 2) | 11 | — | |||||||||||||||||||||
Amortization of intangible assets | 76 | — | |||||||||||||||||||||
Goodwill and intangible asset impairments (Note 3) | 1,827 | — | |||||||||||||||||||||
Amortization of debt issuance costs (Note 4) | 5 | — | |||||||||||||||||||||
Ransomware incident (Note 6) | 4 | — | |||||||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 9) | — | 71 | |||||||||||||||||||||
Non-GAAP | $ | 137 | $ | 49 | 35.5 | % | |||||||||||||||||
Six Months Ended June 30, 2024 | Six Months Ended June 30, 2023 | ||||||||||||||||||||||
Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate | (Loss) Income Before Income Taxes | (Benefit) Provision for Income Taxes | Effective Tax Rate | ||||||||||||||||||
GAAP | $ | 41 | $ | 4 | 8.9 | % | $ | (1,871 | ) | $ | (59 | ) | 3.2 | % | |||||||||
Acquisition and integration costs (Note 1) | 3 | — | 11 | — | |||||||||||||||||||
Restructuring and other (Note 2) | 5 | — | 12 | — | |||||||||||||||||||
Amortization of intangible assets | 123 | — | 157 | — | |||||||||||||||||||
Goodwill and intangible asset impairments (Note 3) | — | — | 1,827 | — | |||||||||||||||||||
Amortization of debt issuance costs (Note 4) | 11 | — | 11 | — | |||||||||||||||||||
Fees and expenses related to amendments to the Term Loan Facility (Note 5) | 3 | — | — | — | |||||||||||||||||||
Ransomware incident (Note 6) | — | — | 11 | — | |||||||||||||||||||
Loss on extinguishment of debt (Note 7) | 47 | — | — | — | |||||||||||||||||||
Foreign tax rate adjustment (Note 8) | — | — | — | 2 | |||||||||||||||||||
Tax effect of Non-GAAP adjustments (Note 9) | — | 46 | — | 95 | |||||||||||||||||||
Non-GAAP | $ | 233 | $ | 50 | 21.7 | % | $ | 158 | $ | 38 | 24.2 | % | |||||||||||
MKS Instruments, Inc.
Notes on Our Non-GAAP Financial Information
Non-GAAP financial measures adjust GAAP financial measures for the items listed below. These Non-GAAP financial measures should be viewed in addition to, and not as a substitute for, MKS’ reported GAAP results, and may be different from Non-GAAP financial measures used by other companies. In addition, these Non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results. Totals presented may not sum and percentages may not recalculate using figures presented due to rounding.
Note 1: Acquisition and integration costs related to the Atotech Acquisition.
Note 2: Restructuring and other costs primarily related to severance costs due to global cost-saving initiatives.
Note 3: During the three months ended June 30, 2023, we noted softer industry demand, particularly in the personal computer and smartphone markets and concluded there was a triggering event at our Materials Solutions Division, which represents the former Atotech business, and Equipment Solutions Business, which represents the former Electro Scientific Industries business and is a reporting unit of our Photonics Solutions Division. We performed a quantitative assessment which resulted in an impairment of
Note 4: We recorded additional interest expense related to the amortization of debt issuance costs associated with our term loan facility.
Note 5: In the first quarter of 2024, we recorded fees and expenses related to an amendment to our term loan facility where we borrowed additional amounts under our USD term loan B and EUR term loan B and fully paid our term loan A.
Note 6: We recorded costs, net of recoveries, associated with the ransomware incident we identified on February 3, 2023. These costs were primarily comprised of various third-party consulting services, including forensic experts, restoration experts, legal counsel, and other information technology and accounting professional expenses, enhancements to our cybersecurity measures, and costs to restore our systems and access our data.
Note 7: During the three and six months ended June 30, 2024, we recorded a charge to write-off deferred financing fees and original issue discount costs related to extinguishment of debt on our USD term loan B and EUR term loan B. Additionally, during the three months ended March 31, 2024 and the six months ended June 30, 2024, we recorded a charge to write-off deferred financing fees related to the extinguishment of our term loan A.
Note 8: During the six months ended June 30, 2023, we recorded a reduction in benefit for income taxes for a retrospective approval of an income tax rate reduction from a foreign jurisdiction.
Note 9: Non-GAAP adjustments are tax effected at applicable statutory rates resulting in a difference between the GAAP and Non-GAAP tax rates.
Note 10: In the fourth quarter of 2023, we modified our definition of Adjusted EBITDA to exclude other (income) expense, net from this Non-GAAP measure. Other (income) expense, net primarily relates to changes in foreign exchange rates. We believe this change enhances investor insight into our operational performance. We have applied this modified definition of Adjusted EBITDA to all periods presented.
FAQ
What was MKS Instruments' (MKSI) revenue for Q2 2024?
How much was MKS Instruments' (MKSI) Adjusted EBITDA in Q2 2024?
What is MKS Instruments' (MKSI) revenue guidance for Q3 2024?